Literature DB >> 15191907

Activation of the systemic and adipose renin-angiotensin system in rats with diet-induced obesity and hypertension.

Carine M Boustany1, Kalyani Bharadwaj, Alan Daugherty, David R Brown, David C Randall, Lisa A Cassis.   

Abstract

In obesity-related hypertension, activation of the renin-angiotensin system (RAS) has been reported despite marked fluid volume expansion. Adipose tissue expresses components of the RAS and is markedly expanded in obesity. This study evaluated changes in components of the adipose and systemic RAS in diet-induced obese hypertensive rats. RAS was quantified in adipose tissue and compared with primary sources for the circulating RAS. Male Sprague-Dawley rats were fed either a low-fat (LF; 11% kcal as fat) or moderately high-fat (32% kcal as fat) diet for 11 wk. After 8 wk, rats fed the moderately high-fat diet segregated into obesity-prone (OP) and obesity-resistant (OR) groups based on their body weight gain (body weight: OR, 566 +/- 10; OP, 702 +/- 20 g; P < 0.05). Mean arterial blood pressure was increased in OP rats (LF: 97 +/- 2; OR: 97 +/- 2; OP: 105 +/- 1 mmHg; P < 0.05). Quantification of mRNA expression by real-time PCR demonstrated a selective increase (2-fold) in angiotensinogen gene expression in retroperitoneal adipose tissue from OP vs. OR and LF rats. Similarly, plasma angiotensinogen concentration was increased in OP rats (LF: 390 +/- 48; OR: 355 +/- 24; OP: 530 +/- 22 ng/ml; P < 0.05). In contrast, other components of the RAS were not altered in OP rats. Marked increases in the plasma concentrations of angiotensin peptides were observed in OP rats (angiotensin II: LF: 95 +/- 31; OR: 59 +/- 20; OP: 295 +/- 118 pg/ml; P < 0.05). These results demonstrate increased activity of the adipose and systemic RAS in obesity-related hypertension.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15191907     DOI: 10.1152/ajpregu.00265.2004

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  126 in total

1.  The platform for adipose tissue expansion during positive energy balance.

Authors:  Jonathan Krakoff
Journal:  J Clin Endocrinol Metab       Date:  2012-02       Impact factor: 5.958

2.  Increased incidence of diuretic use in critically ill obese patients.

Authors:  Emma J de Louw; Pepijn O Sun; Joon Lee; Mengling Feng; Roger G Mark; Leo Anthony Celi; Kenneth J Mukamal; John Danziger
Journal:  J Crit Care       Date:  2015-02-07       Impact factor: 3.425

3.  Angiotensin AT1 and AT2 receptor antagonists modulate nicotine-evoked [³H]dopamine and [³H]norepinephrine release.

Authors:  Vidya Narayanaswami; Sucharita S Somkuwar; David B Horton; Lisa A Cassis; Linda P Dwoskin
Journal:  Biochem Pharmacol       Date:  2013-07-04       Impact factor: 5.858

Review 4.  Type 2 diabetes mellitus and hypertension: an update.

Authors:  Guido Lastra; Sofia Syed; L Romayne Kurukulasuriya; Camila Manrique; James R Sowers
Journal:  Endocrinol Metab Clin North Am       Date:  2013-12-12       Impact factor: 4.741

5.  ACE2 deficiency reduces β-cell mass and impairs β-cell proliferation in obese C57BL/6 mice.

Authors:  Robin Shoemaker; Frederique Yiannikouris; Sean Thatcher; Lisa Cassis
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-08-04       Impact factor: 4.310

6.  Mineralocorticoid receptor antagonism prevents obesity-induced cerebral artery remodeling and reduces white matter injury in rats.

Authors:  Paulo W Pires; Jonathon L McClain; Sebastian F Hayoz; Anne M Dorrance
Journal:  Microcirculation       Date:  2018-06-07       Impact factor: 2.628

7.  Diet-induced obese rats have higher iron requirements and are more vulnerable to iron deficiency.

Authors:  Jesse Bertinato; Cristina Aroche; Louise J Plouffe; Megan Lee; Zehra Murtaza; Laura Kenney; Christopher Lavergne; Alfred Aziz
Journal:  Eur J Nutr       Date:  2013-10-06       Impact factor: 5.614

Review 8.  Effects of exercise training on chronic inflammation in obesity : current evidence and potential mechanisms.

Authors:  Tongjian You; Nicole C Arsenis; Beth L Disanzo; Michael J Lamonte
Journal:  Sports Med       Date:  2013-04       Impact factor: 11.136

9.  Prolonged treatment with angiotensin 1-7 improves endothelial function in diet-induced obesity.

Authors:  Andreas M Beyer; Deng-Fu Guo; Kamal Rahmouni
Journal:  J Hypertens       Date:  2013-04       Impact factor: 4.844

Review 10.  Targeting hypertension in patients with cardiorenal metabolic syndrome.

Authors:  Edward Rojas; Manuel Velasco; Valmore Bermúdez; Zafar Israili; Peter Bolli
Journal:  Curr Hypertens Rep       Date:  2012-10       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.